Trial Profile
An open, multicenter study to evaluate the urodynamic properties of a local implantation of autologous skeletal muscle-derived cells (SMDCs) in female patients with stress urinary incontinence
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 17 Nov 2015
Price :
$35
*
At a glance
- Drugs ICES 13 (Primary)
- Indications Stress incontinence
- Focus Therapeutic Use
- Acronyms PD
- Sponsors Innovacell Biotechnologie GmbH
- 14 Nov 2015 Status changed from recruiting to completed, as reported by European Clinical Trials Database.
- 20 Apr 2015 New trial record